A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SLx-4090 in combination with metformin
therapy will reduce HbA1c in patients with Type 2 Diabetes more effectively than metformin
therapy alone.